References
- Devjak Novak S, Kuhelj V, Vrečer F, et al. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets. Pharm Dev Technol. 2013;18:343–347.
- Košir D, Ojsteršek T, Baumgartner S, et al. A study of critical functionality-related characteristics of HPMC for sustained-release tablets. Pharm Dev Technol. 2016;1–9. doi:10.1080/10837450.2016.1264417
- The European Pharmacopeia. PhEur. 8th ed. Strasbourg: Council of Europe; 2014.
- Talukdar MM, Michoel A, Rombaut P, et al. Comparative study on xanthan gum and hydroxypropyl methylcellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behavior. Int J Pharm. 1996;129:233–241.
- Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release. 2011;154:2–19.
- Košir D, Vrečer F. The performance of HPMC matrix tablets using various agglomeration manufacturing processes. Drug Dev Ind Pharm. 2017;43:329–337.
- Loggia N, Roe C, Kohya S, et al. Low-shear aqueous granulation of a hydrophilic matrix tablet formulation containing a high polymer content. J Pharm Pharmacol. 1999;51:309.
- Roe C, Wigmore A, Loggia N, et al. Feasibility of high-shear wet granulation for an oral controlled release formulation containing a high percentage of HPMC. J Pharm Pharmacol. 1999;51:230.
- Obara S, Fukui I, Manuyama N, et al. Comparison between direct compression and wet granulation method in the preparation of hydrophilic matrix tablets using hypromellose (HPMC). J Pharm Pharmacol. 2006;76:A-29.
- Darunkaisorn W, Mahadlek J, Phaechamud T. HPMC matrix granule formation: selection of suitable granulating fluid. Thai Pharm Health Sci J. 2009;4:29–45.
- Nellore RV, Rekhi GS, Hussain AS, et al. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration. J Controlled Release. 1998;50:247–256.
- Xu G, Sunada H, Zhang R. Indomethacin controlled release matrix tablet prepared by wet granulation procedure. Chem Pharm Bull. 1997;45:214–216.
- Sheskey PJ, Williams DM. Comparison of low-shear and high-shear wet granulation techniques and the influence of percent water addition in the preparation of a controlled-release matrix tablet containing HPMC and a high-dose, highly water soluble drug. Pharm Technol. 1996;3:80–92.
- Ebube NK, Hikal AH, Wyandt CM, et al. Effect of drug, formulation, and process variables on granulation and compaction characteristics of heterogeneous matrices: Part II. HPMC and PVP. Drug Dev Ind Pharm. 1996;22:561–567.
- Shubair MS. Effect of granule properties on the in-vitro and in-vivo performance of ibuprofen sustained release matrix tablets. Sci Pharm. 2004;72:317–332.
- Timmins P, Delargy AM, Howard JR, et al. Evaluation of the granulation of a hydrophilic matrix sustained release tablet. Drug Dev Ind Pharm. 1991;17:531–550.
- Li CL, Martini LG, Ford JL, et al. The use of hypromellose in oral drug delivery. J Pharm Pharmacol. 2005;57:533–546.
- Rekhi GS, Nellore RV, Hussain AS, et al. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. J Control Release. 1999;59:327–342.
- Huang Y, Khanvilkar KH, Moore AD, et al. Effects of manufacturing process variables on in vitro dissolution characteristics of extended release tablets formulated with hydroxypropylmethylcellulose. Drug Dev Ind Pharm. 2003;29:79–88.
- Gill DS, Rekhi GS, Zellhofer MJ, et al. Identification of critical formulation and processing variables for zidovudine (AZT) extended-release (ER) tablets. Pharm Res. 1995;12:S185.
- Khanvilkar KH, Huang Y, Moore AD. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design. Drug Dev Ind Pharm. 2002;28:601–608.